211 related articles for article (PubMed ID: 31427038)
1. Graves' disease, multinodular goiter and subclinical hyperthyroidism.
Bel Lassen P; Kyrilli A; Lytrivi M; Corvilain B
Ann Endocrinol (Paris); 2019 Sep; 80(4):240-249. PubMed ID: 31427038
[TBL] [Abstract][Full Text] [Related]
2. [Subclinical hyperthyroidism: from diagnosis to treatment].
Corvilain B
Rev Med Brux; 2012 Sep; 33(4):241-5. PubMed ID: 23091927
[TBL] [Abstract][Full Text] [Related]
3. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.
Díez JJ
Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352
[TBL] [Abstract][Full Text] [Related]
4. Observations concerning the natural history of subclinical hyperthyroidism.
Woeber KA
Thyroid; 2005 Jul; 15(7):687-91. PubMed ID: 16053385
[TBL] [Abstract][Full Text] [Related]
5. [Management of multinodular non-toxic goiter].
Petrányi G
Orv Hetil; 1994 Dec; 135(51):2851-2. PubMed ID: 7838520
[No Abstract] [Full Text] [Related]
6. Hyperthyroidism and thyroid cancer.
Edmonds CJ; Tellez M
Clin Endocrinol (Oxf); 1988 Feb; 28(2):253-9. PubMed ID: 3168308
[TBL] [Abstract][Full Text] [Related]
7. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
8. [Subclinical hyperthyrodism, diagnosis and radioiodine therapy].
Kociura-Sawicka A; Rogowski F; Abderlazek S; Parfieńczyk A; Szumowski P; Budlewski T
Przegl Lek; 2005; 62(9):903-7. PubMed ID: 16541727
[TBL] [Abstract][Full Text] [Related]
9. Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts.
Folkestad L; Brandt F; Lillevang-Johansen M; Brix TH; Hegedüs L
Thyroid; 2020 May; 30(5):672-680. PubMed ID: 31984866
[No Abstract] [Full Text] [Related]
10. Treatment in patients with hyperthyroidism due to Graves' disease or toxic multinodular goitre (Plummers disease).
Wils J
Neth J Med; 1990 Jun; 36(5-6):263. PubMed ID: 2395493
[No Abstract] [Full Text] [Related]
11. Approach to the patient with subclinical hyperthyroidism.
Cooper DS
J Clin Endocrinol Metab; 2007 Jan; 92(1):3-9. PubMed ID: 17209221
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
[TBL] [Abstract][Full Text] [Related]
13. Cardiothyreosis: Prevalence and risk factors.
Yazidi M; Chihaoui M; Oueslati H; Chaker F; Rjeb O; Rjaibi S; Ouali S; Slimane H
Ann Endocrinol (Paris); 2019 Sep; 80(4):211-215. PubMed ID: 31235068
[TBL] [Abstract][Full Text] [Related]
14. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
[TBL] [Abstract][Full Text] [Related]
15. Toxic multinodular goiter in the elderly.
Vitti P; Rago T; Tonacchera M; Pinchera A
J Endocrinol Invest; 2002; 25(10 Suppl):16-8. PubMed ID: 12508907
[TBL] [Abstract][Full Text] [Related]
16. Subclinical hyperthyroidism: controversies in management.
Shrier DK; Burman KD
Am Fam Physician; 2002 Feb; 65(3):431-8. PubMed ID: 11858626
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
18. Subclinical hyperthyroidism and atrial fibrillation.
Sawin CT
Thyroid; 2002 Jun; 12(6):501-3. PubMed ID: 12165113
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism and concurrent thyroid cancer.
Vaiana R; Cappelli C; Perini P; Pinelli D; Camoni G; Farfaglia R; Balzano R; Braga M
Tumori; 1999; 85(4):247-52. PubMed ID: 10587026
[TBL] [Abstract][Full Text] [Related]
20. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.
Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada-Charneco M; Lund del Castillo JD
Clin Endocrinol (Oxf); 1997 Sep; 47(3):279-85. PubMed ID: 9373448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
